Actualités étiopathogéniques, diagnostiques et thérapeutiques des schizophrénies à début précoce

Translated title of the contribution: Early-onset schizophrenia: Etiopathogenic, diagnostic, and therapeutic news

Marco Guidotti, Marianna Giannitelli, Claudine Laurent-Levinson, David Cohen

Research output: Contribution to journalArticlepeer-review


Early-onset schizophrenia (EOS) is a recent nosographic entity in child psychiatry, currently defined as a multifactorial brain development disorder. Its etiopathogenesis remains difficult to model, involving genetic and prenatal risk factors, as well as neurodevelopmental deviations. EOS has clinically-specific aspects compared to its adult form, with typically alterations in early development. Furthermore, some symptomatic characteristics require the clinician to look for secondary forms, which are somatic in origin. EOS management should be integrative and include antipsychotic treatment, with regular monitoring for the occurrence of side effects.

Translated title of the contributionEarly-onset schizophrenia: Etiopathogenic, diagnostic, and therapeutic news
Original languageFrench
Pages (from-to)193-196
Number of pages4
JournalInformation Psychiatrique
Issue number3
StatePublished - 2019
Externally publishedYes


  • Child development
  • Childhood schizophrenia
  • Genetics
  • Psychotropic


Dive into the research topics of 'Early-onset schizophrenia: Etiopathogenic, diagnostic, and therapeutic news'. Together they form a unique fingerprint.

Cite this